Inso Bio is a startup based in the United States, most recent round Seed, 1 tracked investor.
Inso Bio is a company headquartered in the United States. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Inso Bio develops an automated in-solution genomic DNA sample preparation technology that reduces multi-step workflows to a single ~40 minute step. Their method is compatible with major sequencing platforms including Illumina, PacBio, and Oxford Nanopore and is targeted at scaling genomics for research and industrial use.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.